CALYTERA US INC – Trademark Portfolio
Entity Type: 03
CALYTERA US INC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include AMANDA, CALYTERA, GRANTIUM, and DECISION ACADEMIC. The owner is based in AUSTIN, TX.
804 LAS CIMAS PARKWAY, SUITE 100
AUSTIN, TX 78746
Showing of trademarks Trademarks
Trademark Classifications
CALYTERA US INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does CALYTERA US INC have?
CALYTERA US INC has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.
What trademark classes does CALYTERA US INC file in?
CALYTERA US INC files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are CALYTERA US INC's most well-known trademarks?
CALYTERA US INC's registered trademark portfolio includes well-known marks such as AMANDA, CALYTERA, GRANTIUM, and DECISION ACADEMIC. These are among 5 currently registered trademarks in the portfolio.
What is CALYTERA US INC's trademark registration success rate?
CALYTERA US INC has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.